Bob Cormier assumed the role of president and CEO of the Rhode Island Life Science Hub in August, stepping into a position aimed at bolstering the state’s life-sciences industry and strengthening its competitive edge against neighboring innovation centers in Massachusetts and New Hampshire. The hub, a quasi-public organization established by state lawmakers in 2023, seeks to nurture growth in the life-science sector through initiatives such as Ocean State Labs, the state’s first life science incubator, which opened in Providence earlier this year.
Cormier’s appointment followed the sudden resignation of former CEO Mark Turco in March, who left after one year to pursue a private-sector opportunity. The board of directors selected Cormier in June, highlighting his extensive background spanning more than 25 years in medical devices and healthcare, including leadership roles in startups, mid-sized companies, and Fortune 500 firms. He previously served as CEO of Sentec, a Swiss-American respiratory and critical-care monitoring company, based in Lincoln, Rhode Island.
In an interview, Cormier emphasized the challenges and opportunities of fostering a local ecosystem capable of competing with larger markets like Massachusetts. Drawing on his experience at Sentec, he identified talent development and clinical integration as key areas. While many highly skilled workers have historically been recruited from Massachusetts, the goal is to build a sustainable talent pipeline within Rhode Island. Additionally, Cormier aims to enhance collaboration between local companies and clinical institutions to expedite the adoption of approved medical devices, ensuring new technologies reach healthcare providers and patients more rapidly.
Since the launch of Ocean State Labs in May, approximately 15 companies have joined the incubator, which has a capacity to house around 30. Cormier noted that activity remains steady, despite the seasonal lull associated with Rhode Island’s summer months. To further stimulate growth, the hub introduced the Founders Compass program, intended to increase awareness and attract six to eight additional companies, including outreach efforts beyond state borders to innovation hotspots such as the San Francisco Bay Area and Cambridge, Massachusetts.
Funding remains a critical concern for the hub’s future. Despite reports suggesting an impending financial shortfall, Cormier clarified that the organization still holds about $15 million, though not all allocated. He stressed the importance of establishing a long-term, decade-spanning investment plan for Rhode Island’s life sciences sector, noting that the hub itself was not included as a line item in the current state budget. However, funding opportunities are tied to a $100 million bond focused on growth industries scheduled for a voter referendum in November, an initiative Cormier and others hope will secure broader financial support.
For Cormier, success will be measured by the growth of the state’s life science workforce, with the ambition to double the number of jobs over the next decade, mirroring Massachusetts’ trajectory following the founding of its life sciences initiative in 2006. Equally important is the translation of scientific innovation into market-ready products that can improve patient care. Achieving these goals will mark significant milestones for Rhode Island’s emerging role in the life sciences arena.